| Literature DB >> 33304739 |
Alice Pomeislová1,2, Lukáš Vrzal1,3, Jaroslav Kozák1, Juraj Dobiaš1, Martin Hubálek1, Hana Dvořáková3, Paul E Reyes-Gutiérrez1, Filip Teplý1, Václav Veverka1,4.
Abstract
The formation of a G-quadruplex motif in the promoter region of the c-MYC protooncogene prevents its expression. Accordingly, G-quadruplex stabilization by a suitable ligand may be a viable approach for anticancer therapy. In our study, we used the 4-(4-methylpiperazin-1-yl)aniline molecule, previously identified as a fragment library screen hit, as a template for the SAR-guided design of a new small library of clickable fragments and subjected them to click reactions, including kinetic target-guided synthesis in the presence of a G-quadruplex forming oligonucleotide Pu24. We tested the clickable fragments and products of click reactions for their G-quadruplex stabilizing activity and determined their mode of binding to the c-MYC G-quadruplex by NMR spectroscopy. The enhanced stabilizing potency of click products in biology assays (FRET, Polymerase extension assay) matched the increased yields of in situ click reactions. In conclusion, we identified the newly synthesized click products of bis-amino derivatives of 4-(4-methylpiperazin-1-yl)aniline as potent stabilizers of c-MYC G-quadruplex, and their further evolution may lead to the development of an efficient tool for cancer treatment.Entities:
Keywords: G-quadruplex; NMR; anticancer therapy; click chemistry; secondary structures
Year: 2020 PMID: 33304739 PMCID: PMC7713561 DOI: 10.1002/open.202000261
Source DB: PubMed Journal: ChemistryOpen ISSN: 2191-1363 Impact factor: 2.911
Figure 1The 11 published compounds (1‐11) which were found as c‐MYC ligands in a previously performed fragment library screen. The FRET and PEA assays suggested fragment 7 as the best ligand and it was therefore selected for further elaboration.
Figure 2A set of 4‐(4‐methylpiperazin‐1‐yl)aniline derivatives containing various chemical moieties. Compounds 12–23 were obtained from commercial sources.
Figure 34‐(piperazin‐1‐yl)aniline‐derived fragment library constructed in the present study. (A) Mono‐amino series. (B) Bis‐amino series. (C) Azides used for CuAAC. Compounds from both series (A and B) are sorted by type of reaction whereby they were prepared.
SAR data summary showing both the FRET and PEA results at 100 μM. The PEA values (ESI, Section 3.3, Supplementary Figure S3.5–S3.9) are determined as a quotient of stop band density of the respective compound divided by the stop band density of the parent compound 7.
|
Cpd. No |
Structure |
PEA at 100 μM |
ΔTm/°C FRET at 100 μM |
|---|---|---|---|
|
|
|
1.0 |
10.4±0.6 |
|
|
|
0.5 |
3.7±0.5 |
|
|
|
0.1 |
3.3±0.4 |
|
|
|
0.1 |
2.4±0.9 |
|
|
|
0.5 |
2.4±0.4 |
|
|
|
0.4 |
−2.3±0.7 |
|
|
|
0.5 |
−1.9±0.3 |
|
|
|
0.5 |
−2.7±0.2 |
|
|
|
0.6 |
−1.4±0.3 |
|
|
|
0.5 |
−2.5±0.4 |
|
|
|
0.7 |
−2.3±0.3 |
|
|
|
0.7 |
3.6±0.5 |
|
|
|
0.9 |
3.6±0.8 |
|
|
|
0.8 |
4.2±0.8 |
|
|
|
0.5 |
3.0±0.8 |
|
|
|
0.6 |
3.9±0.4 |
|
|
|
1.2 |
7.6±0.4 |
|
|
|
0.1 |
3.9±0.1 |
|
|
|
0.3 |
4.1±1.1 |
|
|
|
1.6 |
>35 |
|
|
|
0.5 |
13.0±0.9 |
|
|
|
0.5 |
15.9±1.0 |
|
|
|
1.6 |
29.5±0.3 |
|
|
|
0.1 |
5.6±0.4 |
|
|
|
0.5 |
3.5±0.4 |
|
|
|
0.7 |
5.1±0.7 |
|
|
|
4.5 |
33.9±0.2 |
|
|
|
4.5 |
>35 |
|
|
|
0.1 |
1.0±1.0 |
|
|
|
1.6 |
>35 |
The relative formation yields of compounds 27–38 given by reaction ratios. X‐1, Y‐1, and Z‐1‐the combination reactions of three alkynes with the corresponding azides; A, B and C‐in situ click reactions with and without Pu24 and a control reaction, respectively. The ratio was calculated by comparing the area of specific m/z value from the extracted ion chromatography in LC‐MS experiment.
|
Compound |
CH2 |
Experiment X‐1 |
Experiment Y‐1 |
Experiment Z‐1 | ||||
|---|---|---|---|---|---|---|---|---|
|
|
units |
A/B |
A/C |
A/B |
A/C |
A/B |
A/C | |
|
|
|
1 |
1.8 |
1.3 |
– |
– |
– |
– |
|
|
|
2 |
1.7 |
1.3 |
– |
– |
– |
– |
|
|
|
3 |
4.4 |
3.0 |
– |
– |
– |
– |
|
|
|
1 |
– |
– |
1.4 |
1.2 |
– |
– |
|
|
|
2 |
– |
– |
1.5 |
1.2 |
– |
– |
|
|
|
3 |
– |
– |
2.5 |
1.9 |
– |
– |
|
|
|
1 |
7.1 |
4.7 |
– |
– |
6.6 |
5.1 |
|
|
|
2 |
5.2 |
3.1 |
– |
– |
7.4 |
4.4 |
|
|
|
3 |
22.7 |
10.8 |
– |
– |
55.0 |
42.7 |
|
|
|
1 |
– |
– |
4.8 |
3.8 |
5.4 |
4.5 |
|
|
|
2 |
– |
– |
3.4 |
2.5 |
3.7 |
2.6 |
|
|
|
3 |
– |
– |
9.8 |
5.5 |
16.9 |
10.5 |
FRET and PEA results at 100 μM for commercial compound 7 derivatives 12–23 in comparison to the parent molecule 7.
|
Cpd. No |
PEA at 100 μM |
ΔTm/°C FRET at 100 μM |
|---|---|---|
|
7 |
1.0 |
10.4±0.6 |
|
12 |
0.2 |
3.7±0.5 |
|
13 |
0.2 |
0.0 |
|
14 |
– |
−0.3 |
|
15 |
0.2 |
1.6 |
|
16 |
0.6 |
1.7 |
|
17 |
1.1 |
>35 |
|
18 |
0.2 |
1.1 |
|
19 |
0.3 |
1.8 |
|
20 |
0.1 |
0.9 |
|
21 |
0.2 |
1.2 |
|
22 |
0.2 |
1.1 |
|
23 |
0.2 |
1.1 |
Figure 5Competitive FRET analysis at 25 μM and 10 μM using F‐myc25T and ds26 in the 1 : 10 ratio. The assay was performed only for selected compounds that exhibited significant FRET activity at 50 μM.
Figure 4Comparative FRET analysis at 50 μM using F‐myc25T and FdsT (control), performed with the bis‐amino series in compaison to compounds 7 and 12 of the mono‐amino series.
Figure 9(A) Schematic representation of the Pu24 oligonucleotide. Individual G‐tetrads are color‐coded. (B) Three distinctive classes of binding ligands were identified by changes in the peaks of individual guanine NH groups within the amidic region of 1H NMR.